Tellus Therapeutics
Tellus Therapeutics develops small molecules derived from human maternal breast milk to create therapeutic solutions for neonatal health issues, specifically targeting nutritional and immunological deficiencies in premature infants. Their approach aims to enhance health outcomes and decrease the duration of hospital stays for this vulnerable population.
- Biotechnology
Updated 7 months ago
Funding
Raised to date
$16MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Tellus Therapeutics develops small molecules derived from human maternal breast milk to create therapeutic solutions for neonatal health issues, specifically targeting nutritional and immunological deficiencies in premature infants. Their approach aims to enhance health outcomes and decrease the duration of hospital stays for this vulnerable population.